MARKET

VCYT

VCYT

Veracyte
NASDAQ
44.61
-2.80
-5.91%
After Hours: 44.16 -0.45 -1.01% 19:52 12/05 EST
OPEN
47.38
PREV CLOSE
47.41
HIGH
47.45
LOW
44.14
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
50.71
52 WEEK LOW
22.61
MARKET CAP
3.53B
P/E (TTM)
117.70
1D
5D
1M
3M
1Y
5Y
1D
Veracyte SVP and General Counsel Annie McGuire Reports Disposal of Common Shares
Reuters · 1d ago
Veracyte CFO Rebecca Chambers Reports Disposal of Common Shares
Reuters · 1d ago
Veracyte Is Maintained at Underweight by Morgan Stanley
Dow Jones · 4d ago
Morgan Stanley Maintains Underweight on Veracyte, Raises Price Target to $48
Benzinga · 4d ago
Veracyte assumed with an Underweight at Morgan Stanley
TipRanks · 4d ago
Cathie Wood's Ark Invest weekly recap: Boosts AI and Crypto Bets, Trims Palantir, GitLab, and AMD
Seeking Alpha · 5d ago
Weekly Report: what happened at VCYT last week (1124-1128)?
Weekly Report · 5d ago
Veracyte Inc. Director Evan Jones Reports Sale of Common Shares
Reuters · 11/26 21:28
More
About VCYT
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and help patients to diagnose and treat cancer. The Veracyte Diagnostics Platform delivers cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and an evidence-generation engine, which drives durable reimbursement and guideline inclusion for its tests, along with new insights to support continued innovation and pipeline development. The Company offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna) and bladder cancer (Decipher Bladder). It has developed the noninvasive Percepta Nasal Swab test to help physicians accurately and quickly determine lung cancer risk. All of its tests are serviced through its own Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in South San Francisco, California, San Diego, California and Austin, Texas.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.